Convening in Oklahoma City brought together more than 200 stakeholders, spanning leading businesses, organizations, governments and philanthropies, ...
Qure (QURE) shares have taken a hit after the FDA withdrew support for using Phase I/II data from its AMT-130 Huntington's disease gene therapy in a key regulatory submission. This unexpected shift ...
AI’s future will be defined not by parameter counts, but by the integrity of the data that sustains it. Failures in ...
AI-driven data center growth is straining the power grid. Read why renewable energy companies like FSLR, TSLA, and GNRC ...
Had Pfizer’s Freda Lewis-Hall not stepped in, SpringWorks' rare disease treatment may never have reached patients. Pharmas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback